MedTrace Logo

Study of Immunoadsorption to Treat Severe Atopical Dermatitis Associated With Excessively High Serum IgE Levels

NCT00616096 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2010-01-28

No results posted yet for this study

Summary

The purpose of this study is to determine whether immunoadsorption is effective in the treatment of severe atopic dermatitis associated with excessively high serum IgE levels.

Conditions

  • Dermatitis, Atopic

Interventions

PROCEDURE

immunoadsorption

First cycle: week 1, day 1-5 Second cycle: week 5, day 1-5

Sponsors & Collaborators

  • University of Luebeck

    lead OTHER

Principal Investigators

  • Detlef Zillikens, M. D. · Department of Dermatology, University of Lübeck, Germany

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-01-31
Primary Completion
2009-12-31
Completion
2009-12-31

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00616096 on ClinicalTrials.gov